- Current report filing (8-K)
May 12 2009 - 10:04AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 12,
2009
BRUKER CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
|
|
000-30833
|
|
04-3110160
|
(State or other
jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
40
Manning Road
Billerica, MA 01821
(Address of
principal executive offices)(Zip Code)
Registrants
telephone number, including area code:
(978) 663-3660
Check
the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the reporting obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act
|
o
|
Soliciting
material pursuant to Rule 14a-12 of the Exchange Act
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) Exchange Act
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) Exchange Act
|
Item
7.01 Regulation FD
Disclosure.
On May 12, 2009,
Bruker Corporation (the Company) will participate in the Bank of America and
Merrill Lynch 2009 Healthcare Conference in New York, New York. The slides that will accompany Company
managements presentation are attached hereto as Exhibit 99.1.
The information in this Current Report on Form 8-K,
including
exhibits
attached hereto
,
is being furnished and shall not be deemed filed
for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or otherwise subject to the liabilities of that Section and
shall not be deemed incorporated by reference into any filing by the Company
under the Securities Act of 1933, as amended, or the Exchange Act, unless
specifically identified therein as being incorporated by reference therein.
The slides attached to this Current Report on Form 8-K
as Exhibit 99.1 are also posted on the Companys investor relations
website at http://www.bruker.com.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. 99.1
May 12, 2009
Powerpoint Presentation
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
BRUKER CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
Date: May 12, 2009
|
|
By:
|
/s/ William J. Knight
|
|
|
|
William J.
Knight
|
|
|
|
Chief
Financial Officer
|
3
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024